ARTICLE | Clinical News
APC 366-A: Began a U.S. Phase I trial
November 7, 1994 8:00 AM UTC
Arris Pharmaceutical Corp. (ARRS), South San Francisco Product: APC 366-A small molecule inhibitor of mast cell tryptase enzyme, a regulator of the inflammatory cascade Indication: Asthma Status: Beg...